Results 11 to 20 of about 28,693,335 (281)

Screening and Procedural Guidance for Mitral Transcatheter Edge-to-Edge Repair (M-TEER). [PDF]

J Clin Med
International audienceMitral regurgitation (MR) is a common valvular heart disease associated with significant morbidity and mortality. For patients at high or prohibitive surgical risk, mitral transcatheter edge-to-edge repair (M-TEER) offers a less ...
Zygouri A, Rasmeehirun P, L'Official G, Papadopoulos K, Ikonomidis I, Donal E.   +5 more
europepmc   +4 more sources

CT predicts intraprocedural hemodynamics with computational fluid dynamics in TMVR-ineligible patients undergoing M-TEER. [PDF]

Front Cardiovasc Med
\(\bf Background:\) Hemodynamic outcomes in patients undergoing transcatheter mitral edge-to-edge repair (M-TEER) are difficult to predict. Computational fluid dynamics (CFD) is frequently used in biomedical engineering to simulate blood flow patterns ...
Kirchner J, Gerçek M, Omran H, Kassar M, Gräni C, Praz F, Rudolph F, Rudolph V, Rudolph TK.   +8 more
europepmc   +6 more sources

Prognostic impact of being underweight in patients undergoing mitral TEER: The OCEAN‐Mitral registry

ESC Heart Failure
Aims Mitral transcatheter edge‐to‐edge repair (M‐TEER) is a valid treatment option for severe mitral regurgitation (MR), necessitating accurate risk stratification of M‐TEER candidates for effective patient selection, optimal periprocedural care and ...
Ryosuke Higuchi, Masaki Izumo, Yuki Izumi, Mike Saji, Mitsuaki Isobe, Yoshihiro Akashi, Masanori Yamamoto, Masahiko Asami, Yusuke Enta, Masaki Nakashima, Shinichi Shirai, Shingo Mizuno, Yusuke Watanabe, Makoto Amaki, Kazuhisa Kodama, Junichi Yamaguchi, Toru Naganuma, Hiroki Bota, Yohei Ohno, Masahiro Yamawaki, Hiroshi Ueno, Kazuki Mizutani, Shunsuke Kubo, Toshiaki Otsuka, Kentaro Hayashida, the OCEAN‐Mitral Investigators   +25 more
doaj   +2 more sources

M-TEER During Pregnancy: A Lifeline for Mother and Child. [PDF]

JACC Case Rep
[Figure: see text]
Patrascu A, Fam NP.
europepmc   +3 more sources

Real Time Hemodynamic Monitoring During M-TEER Using Electrical Cardiometry. [PDF]

Catheter Cardiovasc Interv
ABSTRACT Background Mitral regurgitation is a common valvular dysfunction causing patient morbidity and mortality. Mitral transcatheter edge‐to‐edge repair (M‐TEER) allows grasping of valvular leaflets and approximation via a small implant, thus reducing mitral regurgitation (MR).
Goldschmied A, Sigle M, Toskas I, Zdanyte M, Bladt M, Gawaz M, Geisler T.   +6 more
europepmc   +3 more sources

The Evolution and Clinical Significance of M-TEER Device Innovation From the OCEAN-Mitral Registry. [PDF]

JACC Asia
Meemook K, Ngernsritrakul T.
europepmc   +3 more sources

Beyond the Valve: When Kidneys Shape the Destiny of M-TEER Outcomes. [PDF]

JACC Asia
[Figure: see text]
Villablanca PA, Jabri A.
europepmc   +3 more sources

Long-Term Efficacy of Mitral Valve Transcatheter Edge-to-Edge Repair (M-TEER) for Exercise-Induced Mitral Regurgitation in a Cardiac Resynchronization Therapy (CRT) Non-responder: A Three-Year Follow-Up. [PDF]

Cureus
Mitral valve transcatheter edge-to-edge repair (M-TEER), a minimally invasive procedure that uses a clip to join the mitral valve leaflets, has emerged as an established treatment for severe mitral regurgitation (MR) in drug-refractory heart failure (HF).
Yagasaki H, Suzuki T, Watanabe K, Oshima Y, Noda T.   +4 more
europepmc   +2 more sources

Expanding the boundaries of M-TEER: is it time to treat moderate secondary mitral regurgitation? [PDF]

EuroIntervention
Adamo M, Riccardi M.
europepmc   +3 more sources

Nine-Year Follow-Up After M-TEER for Secondary Mitral Regurgitation in a Patient With Cardiogenic Shock. [PDF]

Catheter Cardiovasc Interv
ABSTRACT Background Transcatheter edge‐to‐edge repair (TEER) has become an established therapeutic option for patients with severe secondary mitral regurgitation (SMR). While randomized trials and registry data have reported outcomes up to 5 years, longer follow‐up data remain scarce.
Reithmayer T, Stocker TJ, Weckbach LT, Novotny J, Doldi PM, Kempton H, Massberg S, Näbauer M, Hausleiter J, Stolz L.   +9 more
europepmc   +4 more sources